Regencell Bioscience Holdings L - Payout Ratio History
Payout ratio history for stock RGC (Regencell Bioscience Holdings L).
| Date | Payout ratio |
|---|---|
| December 2020 | 80.73% |
| November 2020 | 80.73% |
| October 2020 | 80.73% |
| September 2020 | 80.73% |
| August 2020 | 80.73% |
| July 2020 | 80.73% |
| June 2020 | 80.73% |
| May 2020 | 80.73% |
| April 2020 | 80.73% |
| March 2020 | 80.73% |
| February 2020 | 80.73% |
| January 2020 | 80.73% |
| December 2019 | 80.73% |
| November 2019 | 80.73% |
| October 2019 | 80.73% |
| September 2019 | 80.73% |
| August 2019 | 80.73% |
| July 2019 | 80.73% |
| June 2019 | 80.73% |
| May 2019 | 80.73% |
| April 2019 | 80.73% |
| March 2019 | 80.73% |
| February 2019 | 80.73% |
| December 2018 | 80.73% |
| December 2017 | 101.20% |
| December 2016 | 80.70% |
| December 2015 | 94.60% |
| December 2014 | 164.20% |
| December 2013 | 76.30% |
| December 2012 | 90.30% |
| December 2011 | 253.10% |
| December 2010 | 144% |
| December 2009 | 116.10% |
| December 2008 | 255.30% |
| December 2007 | 176.09% |
| December 2006 | 161.43% |
| December 2005 | 192.68% |
| December 2004 | 124.47% |
| December 2003 | 89.12% |
| December 2002 | 66.57% |
RGC
Price: 21.67USD
52 week range price:
Dividend Yield: 3.83%
Forward Dividend Yield: 3.83%
Payout Ratio Range:
Earnings Per Share: 1.09 USD
P/E Ratio: 26.12
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Volume: 700
Ebitda: 521.8 millionMarket Capitalization: 300.3 million